Fenodac 135mg Capsule
By Fenodac
Rx
10 Capsule in a Strip

Composition
Fenofibrate(135mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
October, 2025

liver
When it comes to the liver, caution should be taken with Fenodac 135mg Capsule. It is likely unsafe for individuals with liver disease and should be avoided. If you have a history of liver problems or are currently dealing with severe liver disease, it is best to refrain from using this medication. It is strongly advised to consult with your doctor before starting any treatment involving Fenodac 135mg Capsule to ensure your liver health is protected.

kidney
Fenodac 135mg Capsule should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Consult your doctor.

alcohol
Consuming alcohol with Fenodac 135mg Capsule is not safe. It is important to avoid alcohol when taking this medication.

driving
Fenodac 135mg Capsule typically does not impact driving ability.

pregnancy
Fenodac 135mg Capsule may not be safe for use during pregnancy, based on limited human studies and harmful effects observed in animal studies. Consult your doctor for a thorough evaluation of the benefits and risks before taking this medication.

breastfeeding
Fenodac 135mg Capsule may not be safe during breastfeeding as it can pass into breastmilk and potentially harm the baby. It is important to exercise caution and consult your healthcare provider before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | PPAR alpha |
Therapeutic Class | - |
Action Class | PPAR alpha agonists (Fibrate) |
₹119.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025